Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Core EBITDA Growth

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2013Mar2012
   Core EBITDA Growth(%) 2.1126.7790.8131.43-

What is the latest Core EBITDA Growth ratio of NATH BIOGENES (INDIA) ?

The latest Core EBITDA Growth ratio of NATH BIOGENES (INDIA) is 2.11 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar20242.11
Mar202326.77
Mar202290.81
Mar201331.43
Mar2012-

How is Core EBITDA Growth of NATH BIOGENES (INDIA) Trending?

Years Core EBITDA Growth % Change
Mar2024 2.11
-92.12
Mar2023 26.77
-70.52
Mar2022 90.81
188.93
Mar2013 31.43
0
Mar2012 0 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare Core EBITDA Growth ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹400.9 Cr 6.7% 9.8% -2.7% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹13,428.7 Cr 2.1% -3.7% 12.1% Stock Analytics
KAVERI SEED COMPANY ₹6,112.0 Cr -5.6% -20.5% 25.5% Stock Analytics
VENKYS (INDIA) ₹2,273.2 Cr 0.5% 0.4% -18.6% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,485.6 Cr 7.8% 2.6% -31.5% Stock Analytics
INDO US BIOTECH ₹305.6 Cr -0.1% -4.1% -33% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

6.7%

9.8%

-2.7%

SENSEX

1.6%

0.7%

6.8%


You may also like the below Video Courses